European Pharmaceutical Review

NOVEMBER 10, 2023

According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging. The construction projects will be finalised from the end of 2025 through to 2029. Most of the investment will be focused on API capacity.

Packaging 111

Packaging Pharmaceutical Manufacturing Diabetes 111

Express Pharma

JUNE 8, 2023

The introduction of Velocity Vials will contribute to the ongoing evolution of our offerings and services and will expand our portfolio of high-quality tubular glass packaging. Pharma tubing production is expected to begin in 2025. Manufacturing of Velocity Vials at SGD Pharma’s facility in Vemula, India, is expected to begin in 2024.

Packaging 96

Packaging 96

National Association of Boards of Pharmacy

OCTOBER 23, 2024

Exchanging transaction information, verifying product identifiers, responding to regulator requests for transaction information, and gathering transaction information at the package level. For wholesalers, these exemptions are granted until August 27, 2025.

Packaging 49

Packaging Documentation Pharmacy Technician 49

European Pharmaceutical Review

MAY 14, 2024

At its Le Trait site in Normandy, Sanofi added that it will devote €100 million for new capacity for biologics formulation, filling, device assembly and packaging. Sanofi shared that it plans to launch in 2025. Sanofi expects that 350 jobs will be created at the facility following this investment. The facility will be low-carbon.

Vaccines 98

Vaccines Packaging Diabetes 98

Express Pharma

JUNE 3, 2024

package insert. by the 2024/2025 respiratory virus season,” the statement informs. A follow-up analysis of the primary endpoint was performed during FDA review, including cases that started before the primary analysis cut-off date but were not confirmed until afterward. The results were consistent with the primary analysis [VE 78.7

Vaccines 80

Vaccines Adverse Reactions Packaging 80

European Pharmaceutical Review

NOVEMBER 23, 2023

CPI confirmed that the centre will establish operations during 2024 and be finished in late 2025. This is a first-of-its-kind collaboration for the pharma industry. Partners include AstraZeneca, GSK, and the University of Strathclyde. The project will be jointly funded by the UK and Scottish Governments.

Packaging 104

Packaging 104

European Pharmaceutical Review

AUGUST 17, 2022

The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.

Pharmaceutical Manufacturing 96

Pharmaceutical Manufacturing Dosage Packaging Labelling 96

Pharmaceutical Technology

JUNE 19, 2023

It is critical to understand the supply chain, plan your packaging, storage and distribution lanes, then test the entire process before patient shipments go live. Products are stored and packaged in a dedicated suite by a dedicated team,” explains MacNeir. The requirements When handling personalised medicines, time is of the essence.

Packaging 52

Packaging Compounding Communication Pharmaceutical Companies 52

Express Pharma

SEPTEMBER 5, 2023

Over the years, we have continued to seek improvements to existing molecules to better meet patient needs – we have introduced novel heat-stable generic formulations, more convenient packaging options, and paediatric therapies.

Packaging 97

Packaging 97

European Pharmaceutical Review

SEPTEMBER 15, 2022

The plant is specialised in the purification and filling of plasma-derived therapies, with packaging capabilities for a variety of plasma treatments. People with these conditions may require lifesaving treatment for acute emergencies, as well as lifelong substitution therapy.

Packaging 98

Packaging 98

FDA Law Blog: Biosimilars

MARCH 21, 2024

As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.

Packaging 62

Packaging Communication 62

Pharmaceutical Technology

APRIL 21, 2023

While the FDA sent Lilly a complete response letter detailing issues pertaining to the proposed manufacturing of mirikizumab, the regulator raised no concerns about the clinical data package or label for the medicine. The recent setback dents mirikizumab’s chances to be the first among the IL-23 inhibitors to launch in the US for UC.

Packaging 52

Packaging Labelling 52

Pharmaceutical Technology

NOVEMBER 22, 2022

The Chinese government announced its ten-year 'Made in China 2025' strategic plan in 2015, which aimed to make the country a global leader in several high-tech industries. These industries unexpectedly also included biotech, which was not a particularly strong area for Chinese manufacturing, which is more recognised for generics production.

Biosimilars 64

Biosimilars Packaging Vaccines 64

Pharmaceutical Technology

NOVEMBER 1, 2022

“The medicines regulators in Europe have a strategy for 2025 where the second pillar is data and digitalisation, so we are trying to transform medicines regulation to be data-driven,” says Peter Arlett, Head of Data Analytics and Methods Task Force at EMA. Arlett explains that Darwin EU is playing a collaborative role in this goal.

Medical Records 111

Medical Records Packaging Vaccines 111

Express Pharma

SEPTEMBER 3, 2024

Giving the equipment manufacturer’s point of view, Shivshankar SR, CEO, ACG Packaging Materials, reiterates that it is important for organisations to proactively set targets and focus on long-term initiatives that will provide value realisation and business transformation towards creating a more sustainable and resilient future.

Packaging 108

Packaging Biosimilars Communication Pharmaceutical Companies 108

Pharmaceutical Technology

MAY 23, 2023

While a handful of incentives are offered by the reform package, they are overshadowed by the potential drawbacks for the innovative sector. The passage of legislation is not anticipated before the next EU parliamentary elections in 2024, potentially resulting in delays until late 2024 or even 2025.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Packaging 52

Fuld & Company Blog

APRIL 6, 2023

The leading IOC in the new electricity market is BP, which, through its subsidiary Lightsource bp, is projecting the sale of 25 GW of green electricity projects by 2025, but with only 4 GW of associated storage, or just 3% of the IEA’s projected 2025 demand of 148 GW. This includes trading and microgrid packages.

Packaging 52

Packaging 52

Fuld & Company Blog

MAY 15, 2023

Technology was used to handle costly administration issues. The Resulting Package By 2020, it was clear that One Medical was hitting a positive note with the market, and so it went public. If in-person, when patients arrived at the clinic, they would only see a receptionist and a doctor. Prime and, of course, One Medical members.

Health and Personal Care Stores 59

Health and Personal Care Stores Mail-Order Pharmacies Packaging Medication Delivery 59

Quality Matters

APRIL 19, 2024

Expanding PEPFAR’s procurement goals There are currently about 600 manufacturers producing packaged medicines in Africa , with 80 percent of those producers concentrated in just eight countries. By 2025, PEPFAR aims to procure 15 million HIV tests from African manufacturers. But PEPFAR is looking to change how it does business.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Vaccines 52

pharmaphorum

DECEMBER 13, 2021

It, too, announced plans to invest $500 million in a new facility in Africa for the production, fill/finish and packaging of mRNA vaccines. The company also presented results in November for their AstraZeneca-partnered mRNA candidate for heart failure. Some of that funding will go towards expanding the mRNA team to 400 staff.

Vaccines 103

Vaccines Packaging 103

European Pharmaceutical Review

FEBRUARY 7, 2023

From 31 January 2025, new and ongoing clinical trials in the EU must be conducted in compliance with the CTR. Authorisation of the clinical trial, may, however, be obtained later. The proposed revisions will form the basis of the future regulation of the pharmaceutical industry in the EU and are anticipated for publication in mid-March.

Packaging 117

Packaging Drug Development 117

STAT

SEPTEMBER 23, 2022

… The White House is pitching an added benefit to the recent drug-pricing reform package: lower cancer death rates , STAT explains. A  A new analysis by the Council of Economic Advisers focused on a provision that caps Medicare out-of-pocket costs for pharmacy drugs at $2,000 a year, starting in 2025.

Drug Pricing 232

Drug Pricing Packaging 232

Pharmaceutical Technology

JULY 29, 2022

Injectables and their packaging requirements have never been more important to marketed treatments, given the volume of vaccines being packaged that are required to tackle the Covid-19 pandemic, as well as the rising presence of biologics in pipelines and their marketed approvals. with BARDA (Washington DC).

Vaccines 52

Vaccines Packaging Immunity Immunization 52

PharmaShots

JUNE 7, 2023

Amgen will be allowed to sell its ustekinumab biosimilar no later than Jan 2025 Amgen highlighted the preliminary results from a P-III study which showed no clinical differences b/w ABP 654 and Stelara in adults with mod. PsO Ustekinumab, an anti-IL-12/IL-23 Ab drug indicated to treat PsO, PsA, CD, and UC.

Biosimilars 40

Biosimilars Packaging Diabetes Pharmaceutical Companies 40

Putting Patients First Blog

SEPTEMBER 30, 2024

With the funding deadline occurring after the November elections, the next round of negotiations will be impacted by the election results. Medicare and Medicaid Extensions Established in 2008, the goal of the Medicare Improvement Fund is to improve upon the original Medicare program, primarily Parts A and B.

Department of Veterans Affairs 52

Department of Veterans Affairs Packaging Drug Development 52

Putting Patients First Blog

MARCH 18, 2024

The requirement for Part D sponsors to provide translated materials in any non-English language that is the primary language of at least five percent of individuals in a Plan Benefit Package (PBP) service area is a step in the right direction towards addressing health disparities and promoting equity in health care access.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Mail-Order Pharmacies 40

Putting Patients First Blog

MARCH 18, 2024

The requirement for Part D sponsors to provide translated materials in any non-English language that is the primary language of at least five percent of individuals in a Plan Benefit Package (PBP) service area is a step in the right direction towards addressing health disparities and promoting equity in health care access.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Mail-Order Pharmacies 40

PharmaShots

JUNE 1, 2023

These new results reinforce our differentiating data package for PDC*lung01. After the completion of the current clinical study with PDC*lung01 (PDC-LUNG-101), we plan to conduct a randomized, open-label phase 2 clinical trial with PDC*lung in the B2 cohort setting (2025 to 2028).

Immunization 40

Immunization Immunity Vaccines Health and Personal Care Stores 40

PharmaShots

FEBRUARY 1, 2023

and nurse support services & pharmacy support services to eligible patients. The biosimilar will be used to treat and prevent osteoporosis and cancer-related skeletal complications Under the terms of the agreement, HK inno.N no significant difference b/w groups in BCVA @6 & 12mos.

Biosimilars 40

Biosimilars Packaging Diabetes Hospitals 40

STAT

SEPTEMBER 23, 2022

WASHINGTON — The White House is pitching an added benefit to Democrats’ recent drug pricing reform package: lower cancer death rates. A new analysis by the Council of Economic Advisers focused on the new law capping Medicare patients’ out-of-pocket costs for pharmacy drugs at $2,000 per year, starting in 2025.

Drug Pricing 250

Drug Pricing Packaging 250

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Putting Patients First Blog

JUNE 5, 2023

Debt Ceiling Legislation Passed June 5, 2023 By: Allen Pinn, Coordinator, Policy After months of back and forth between President Biden and Speaker McCarthy, a debt ceiling package was signed into law on June 3, suspending the debt ceiling until January 1, 2025, and avoiding economic catastrophe.

Packaging 52

Packaging 52

STAT

SEPTEMBER 13, 2024

  Tax credit complications Before diving into the candidates and their platforms, there is an imminent issue in Congress that could affect the market regardless of who is in the White House: the expiration of enhanced tax credits in 2025. million people.

Packaging 266

Packaging 266